Atlas Trials

A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)

Clinical trial NCT00846391 · TERMINATED

Trial details

NCT number
NCT00846391
Sponsor
Merck Sharp & Dohme LLC
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2008-12-01
Primary completion
2009-08-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.